Akèy › Tit travay › Sr. Scientist
Sr. Scientist: Salè H-1B
171 aplikasyon kondisyon travay te itilize tit travay Sr. Scientist. Salè baz medyàn ofri $112,810; mwatye mitan $103,251–$139,996.
Demann (LCA)171
Salè medyan ofri$112,810
Mwatye salè yo$103,251–$139,996
10yèm–90yèm pousantaj$90,000–$149,827
Avoka imigrasyon, rekritè oswa anplwayè? Mete sèvis ou an tèt paj sa a — $99 pou 30 jou →
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|
| St. Jude Children's Research Hospital | 33 | $104,000 |
| Regeneron Pharmaceuticals, Inc. | 23 | $142,799 |
| Amgen Inc. | 16 | $149,827 |
| Eli Lilly and Company | 14 | $103,815 |
| PPD Development, L.P. | 4 | $66,696 |
| Novitium Pharma LLC. | 4 | $93,392 |
| Dexcom, Inc. | 3 | $132,175 |
| Premier Nutrition Company, LLC | 3 | $140,476 |
| Illumina, Inc. | 3 | $101,442 |
| Dana-Farber Cancer Institute | 3 | $126,000 |
| Anwita Biosciences Inc | 3 | $135,169 |
| Uber Technologies, Inc. | 3 | $188,300 |
| Verdagy, Inc. | 2 | $120,000 |
| Tate & Lyle Solutions USA, LLC | 2 | $99,112 |
| West Technology Group, LLC | 2 | $101,344 |
| Bio-Rad Laboratories, Inc. | 2 | $114,356 |
| South Chicago Packing LLC | 2 | $88,042 |
| Xencor, Inc. | 2 | $125,000 |
| Ionis Pharmaceuticals, Inc. | 2 | $118,040 |
| Parsons Technical Services Inc. | 2 | $89,082 |
| Programmable Medicine Operating Company | 2 | $162,000 |
| University of New Mexico | 2 | $84,178 |
| GDB International, Inc. | 1 | $165,000 |
| Aon Benfield, Inc. | 1 | $93,000 |
| Trampoline Pharma Inc. | 1 | — |
| TCG GreenChem, Inc | 1 | $90,000 |
| Ultima Genomics, Inc. | 1 | $116,813 |
| Atara Biotherapeutics, Inc. | 1 | $94,000 |
| UIH America, Inc. | 1 | $102,003 |
| Impossible Foods Inc. | 1 | $115,690 |
| Abbvie Biotherapeutics Inc. | 1 | $133,000 |
| Dewpoint Therapeutics, Inc. | 1 | $137,200 |
| DxTerity Diagnostics Inc. | 1 | $90,000 |
| Cosmobiolabs Inc. | 1 | $110,000 |
| Elementis Specialities Inc. | 1 | $126,240 |
| ModernaTX, Inc. | 1 | $125,500 |
| Advanced Cell Diagnostics, Inc. | 1 | $130,000 |
| Presbyterian Healthcare Services | 1 | $92,602 |
| The Clorox Services Company | 1 | $105,000 |
| Alcon Research, LLC | 1 | $81,515 |
| Sigma-Aldrich Manufacturing LLC | 1 | $115,000 |
| Outokumpu Stainless USA, LLC | 1 | $125,000 |
| James R. Glidewell Dental Ceramics, Inc. | 1 | — |
| Pentangle Tech Services LLC | 1 | $135,200 |
| Uswm CT, LLC | 1 | $120,211 |
| Catalent Indiana, LLC | 1 | $94,667 |
| FUJIFILM Diosynth Biotechnologies Texas LLC | 1 | $75,000 |
| Cytovance Biologics, Inc | 1 | $90,000 |
| Greatbatch Ltd. | 1 | $128,000 |
| Alsym Energy Inc. | 1 | $160,000 |
| Janssen Research & Development, LLC | 1 | $114,608 |
| Syensqo USA LLC | 1 | $124,000 |
| Corning Research & Development Corporation | 1 | $116,278 |
| AnaBios Corporation | 1 | $113,304 |
| Sanofi US Services Inc. | 1 | $136,552 |
| Chr. Hansen, Inc. | 1 | $128,564 |
| AbbVie Inc. | 1 | $156,000 |
| Bayer Research and Development Services LLC | 1 | $123,009 |
| Sutro Biopharma, Inc. | 1 | $162,137 |
| Nestle Purina PetCare Global Resources, Inc. | 1 | $107,000 |
Pa nivo salè
| Nivo revni | Salè medyan |
|---|
| Nivo I (antre) | $83,000 |
| Nivo II (kalifye) | $117,832 |
| Nivo III (eksperyans) | $104,000 |
| Nivo IV (plen kompetans) | $124,000 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|
| FY2023 | 20 | $103,251 |
| FY2024 | 38 | $104,000 |
| FY2025 | 43 | $104,000 |
| FY2026 | 65 | $136,552 |
Vil yo
- Memphis, TN33
- Tarrytown, NY23
- Thousand Oaks, CA11
- San Diego, CA7
- Boston, MA6
- Indianapolis, IN5
- South San Francisco, CA5
- East Windsor, NJ5
- Cambridge, MA4
- Watertown, MA4
- Chicago, IL3
- Emeryville, CA3
- Redwood City, CA3
- San Carlos, CA3
- New York, NY3
- Albuquerque, NM3
- Moss Landing, CA2
- Hoffman Estates, IL2
- Omaha, NE2
- Pasadena, CA2
- Carlsbad, CA2
- Louisville, CO2
- Silver Spring, MD2
- St. Louis, MO2
- Irvine, CA2
- Nashville, IL1
- Aurora, CO1
- Ewing, NJ1
- Pleasanton, CA1
- Fremont, CA1
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).